IMS Health - SWOT Analysis
| Publication Date | September 2007 |
|---|---|
| Publisher | Datamonitor |
| Product Type | Report |
| Pages | 31 |
| ISBN Number | not applicable |
| Product Code | DAT07696 |
Summary
Datamonitor's IMS Health Company Profile is the essential source for top-level company data and information. The report examines the company's key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
IMS Health (IMS) provides information and consulting services to the pharmaceutical and healthcare industries. The company has three business areas including the provision of sale management information, market research for pharmaceutical companies, and consulting. It is headquartered in Norwalk, Connecticut and employs about 7,400 people. The company recorded revenues of $1,958.6 million during the fiscal year ended December 2006, an increase of 11.6% over 2005. The operating profit of the company was $444.2 million during fiscal year 2006, an increase of 5.6% over 2005.The net profit was $315.5 million in fiscal year 2006, an increase of 11.1% over 2005.
Scope of the Report
- Provides all the crucial company information required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting the company in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams
- Data is supplemented with details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement
Reasons to Purchase
- Support sales activities by understanding your customers' businesses better
- Qualify prospective partners and suppliers
- Keep fully up to date on your competitors' business structure, strategy and prospects
- Obtain the most up to date company information available
Content
- Key Facts
- Company Overview
- Business Description
- Company History
- Key Employees
- Key Employee Biographies
- Company View
- SWOT analysis
- Products & Services Listing
- Products & Services Analysis
About this Product
Delivery Details
PDF:Delivered by email usually within 4 to 8 UK business hours.
Related Products
- AstraZeneca’s Crestor Could Revolutionise Heart Disease Treatment >>
- Sanofi-Aventis and Pfizer Stop Development of a Class of Anti-obesity drugs >>
- Pharma Companies turn Webwards to Recruit Patients as 90% of Clinical Trials Face Delay >>
- Have your Healthcare Costs Reduced with Personalized Healthcare >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Chemicals
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
Resources
Why Report Buyer?
Advertising/Affiliates
View Our Publishers
News
About Us
Market Publishers
Meet Us
Jobs
Contact Us
Categories and Subcategories















